ChrysCapital 700 crore investment in Corona Remedies
Homegrown private equity fund ChrysCapital has invested about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies.
ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said.